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ABSTRACT 
MOTIVATIONAL INTERVIEWING IN PRIMARY CARE AND GENERAL HEALTH 
CARE SETTINGS: A META-ANALYSIS 
  
by 
  
Michele K. Olson 
  
The University of Wisconsin-Milwaukee, 2015 
Under the Supervision of Dr. Mike Allen 
          
 The rate of mortality and morbidity due to alcohol consumption warrants a 
comprehensive and evidence-based investigation exploring the efficacy of behavioral 
interventions within a general health care setting as a means of alcohol reduction. A 
particular type of intervention, known as Motivational Interviewing (MI; Miller, 1983) 
and Motivational Enhancement Therapy (MET; Miller, Sovereign, & Krege, 1988), both 
of which have seen surge in popularity, merits further inspection. Through electronic 
database searching, hand searching previous meta-analyses and systematic reviews, and 
searching the Motivational Network of Trainers bibliographic resource, 33 randomized 
controlled trials were located isolating the effect of motivational interviewing in general 
health care settings. The average effect (𝑑 = .153 k = 33, N = 32,588) constitutes a small 
effect in favor of MI and/or MET, with no substantial benefit in offering MET (𝑑 =  .125, 
(95% CI [0.044, 0.206], N = 21,226) as opposed to MI (𝑑 = .114, (95% CI [0.06, 0.016], 
N = 8689). MI and/or MET produces a small benefit within primary care and is relatively 
comparable to other brief interventions within the same setting. Primary care providers 
wishing to implement MI/MET within their practice may be reasonably assured that 
MI/MET will be more effective in improving patient outcomes than delivering no 
intervention.
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MOTIVATIONAL INTERVIEWING IN PRIMARY CARE AND GENERAL HEALTH 
CARE SETTINGS: A META-ANALYSIS 
  
         In 2012, alcohol consumption was responsible for 3.3 million deaths worldwide, 
equating to 5.9% of all global mortalities (World Health Organization [WHO], 2014). In 
the United States, excessive alcohol consumption (see Table 1) constitutes the third 
leading lifestyle-related cause of death, with approximately 88,000 deaths from 2006-
2010 (Centers for Disease Control [CDC], 2013). In addition to the fatalities associated 
with alcohol consumption, a causal relationship exists between an individual’s average 
level of alcohol consumption and more than 60 diseases (Rehm et al., 2004). The 
morbidity consequences are both acute (e.g., intentional and unintentional injury) and 
chronic (e.g., cardiovascular disease, certain types of cancer, gastrointestinal diseases) 
(WHO, 2014). 
         Furthermore, alcohol consumption does not solely affect the individual user in 
terms of adverse health outcomes or mortality. Close others (e.g., spouse or partner, 
child, or friend) may be harmed as well, primarily through violence and aggressive 
behaviors (National Institute of Alcohol Abuse and Alcoholism [NIAAA], 1997; WHO, 
2014). Even individuals not in proximity with a problematic drinker face economic 
consequences at the hand of a distant alcohol consumer, considering excessive alcohol 
consumption costs American citizens approximately $185 billion annually in related 
health care costs, criminal justice expenses and loss of productivity (CDC, 2011). 
         Due to the burden placed on both the individual and society at large, there is a 
robust effort to reduce Americans’ alcohol consumption. A variety of public policies, 
such as increasing alcohol taxes or placing harsher consequences on intoxicated driving, 
seek to reduce national alcohol consumption (Alcohol and Public Policy Group, 2010). 
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Within the American health care system, the prevention and treatment of alcohol use 
disorders (see Table 1) receive increased attention, both in terms of research production 
and resource allocation. 
         The following sections provide a brief overview of alcohol treatment within the 
United States, with a focus on the importance of delivering alcohol treatment within 
primary care and general health care settings. Next, a summary of the process of 
Screening and Brief Intervention (SBI), a common practice in primary health care will be 
examined. A specific and popular type of brief intervention, Motivational Interviewing, 
will be outlined, with an emphasis on the communication centered causal mechanisms of 
the theory. Finally, a review of previous meta-analyses synthesizing Motivational 
Interviewing application will highlight the past the methodological issue of combining 
treatment seeking and non-treatment seeking populations.  
Alcohol Treatment Within the United States 
         For individuals diagnosed with an alcohol use disorder (AUD), various treatment 
options exist. These include inpatient rehabilitation services, outpatient treatment and the 
use of pharmaceutical medications, such as disulfiram, naltrexone, and acamprosate 
(Fuller & Hiller-Sturmhofel, 1999). Commonly, inpatient treatment, colloquially referred 
to as “rehab,” is a residential treatment program that provides services such as therapy 
(both individual and group) and alcohol education (Fuller & Hiller-Sturmhofel, 1999). 
For those with a less severe AUD, an outpatient treatment service (e.g., day hospital 
programs) may be more appropriate. Typically, patients submit to a facility for several 
hours per day, which allows them to maintain familial responsibilities (Fuller & Hiller-
Sturmhofel, 1999). Either type of treatment may be supplemented with pharmacotherapy 
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using aversive (e.g., disulfiram) or anti-craving medications (e.g., naltrexone and 
acamprosate) to aid the patient in maintaining abstinence (Fuller & Hiller-Sturmhofel, 
1999). 
         Unfortunately, the majority of those at risk or diagnosed with AUD fail to enter 
inpatient or outpatient treatment, with only a small fraction “enter[ing] a qualified 
treatment program” (Heinz, Wilwer & Mann, 2003, p. 706). To illustrate, in Germany 
only 2% of those with AUDs enter specialized rehabilitation facilities (Heinz et al., 
2003). Due to the poor rate of patient voluntary commitment to formal alcohol treatment, 
efforts have shifted to preventing AUDs before they manifest, and providing alcohol 
treatment at locations where a majority of patients receive health care. And the setting in 
which most at-risk drinkers present for health services are primary care clinics and other 
general health care settings (Fleming & Manwell, 1999).  
Alcohol Prevention Within A General Health Setting 
         Within the developed world, 85% of the population visits a primary care 
physician (PCP) annually for services ranging from a routine check-ups, management of 
specific health conditions and acute illness treatment (Barbor & Higgens-Biddle, 2001; 
Fleming & Manwell, 1999; Henry-Edwards, Humenik, Moneiro & Poznya, 2003). 
Through the volume of patients in contact with a PCP or other general health care 
provider (e.g., nurse, nurse practitioner, internist in a hospital), there exists an opportunity 
to detect and aid those with a range of alcohol issues (e.g., opportunistic screening and 
intervention). Heavy drinkers (see Table 1), in particular consult a PCP more frequently 
than the general public, most likely due to an increased likelihood of chronic disease 
(Anderson, 1996). Research by Manwell, Fleming, Johnson and Barry (1998) examined 
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the prevalence of alcohol use within a primary care setting by screening approximately 
21,300 adults ages 18-65. Results indicate that approximately 23% of persons 
encountering a physician met the standards for an at-risk classification as a problem or 
dependent alcohol user. 
         Although epidemiological analyses support how essential primary care is in the 
treatment of alcohol problems, PCPs often display reluctance to deliver interventions in 
order to help patients decrease or eliminate alcohol consumption (Fleming & Manwell, 
1999). PCP reluctance may reflect the widespread belief that treatment for alcohol 
problems requires an intensive treatment and delivery by alcohol specialists (Bien, Miller 
& Tonigan, 1993). Through interviews with 36 PCPs, Aira, Kauhanen, Larivaara and 
Rautio (2003) categorized the predominant reasons why PCPs feel uncertain about 
delivering alcohol interventions in their clinics. Reasons include (a) the idea that alcohol 
consumption constitutes a more sensitive issue than other health conditions, (b) the belief 
that interventions are ineffective, and (c) feeling ill equipped and unsuited to address 
unhealthy alcohol consumption. While alcohol consumption constitutes an uncomfortable 
conversation, the other prevailing fears are generally unfounded, considering the 
demonstrated effectiveness of interventions (Bien, Miller & Tonigan, 1993), and the 
conclusion that the delivery of such interventions by a PCP can be just as effective as 
those delivered by an alcohol specialist (see Drummond, Thom, Brown, Edwards & 
Mullan, 1990). 
         In order to dispel the pervading myths and increase the likelihood that 
interventions will be utilized within a primary care or general health setting, numerous 
health organizations and international governments provide recommendations and 
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guidelines for undertaking interventions in primary and routine health care. Many of the 
recommendations and guidelines occur in developed areas (e.g., Europe and the United 
States), as alcohol consumption is highest in more economically developed regions 
(Alcohol and Public Policy Group, 2010). For example, the Primary Health European 
Project on Alcohol (PHEPA), funded by the European Commission, is involved with 
incorporating interventions into PCPs’ daily clinical work (Primary Health European 
Project on Alcohol, 2012). In Sweden, the government-funded “Swedish Risk Drinking 
Project" aims to give alcohol issues an increased place in routine health care encounters 
(Nilsen, Wahlin & Heather, 2011). In the United Kingdom, the National Health Service 
gives general practitioners the responsibility to screen and provide interventions for 
patients considered “at risk” (Barbor & Higgins-Biddle, 2000). 
         Importantly in the United States, The United States Preventative Task Force 
(USPTF) currently “recommends that clinicians screen adults aged 18 years or older for 
alcohol misuse and provide persons engaged in risky or hazardous drinking with brief 
behavioral counseling interventions to reduce alcohol misuse” (USPTF, 2013, p. 210). 
This process is commonly recognized as Screening and Brief Intervention (SBI). 
Increased opportunity exists for expanding SBI in a variety of health contexts, as the 
Affordable Care Act (ACA) now requires all employer and Medicare insurance plans to 
cover prevention services that the USPSTF has stated are effective (Brolin et al., 2012). 
The SBI process recommended by the USPTF underscores the two primary goals within 
a primary care-based approach: the detection of those with an alcohol issue through 
screening efforts, and subsequent behavioral treatment (i.e., brief intervention). 
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         Screening. Screening refers to “a systematic process of identifying patients 
whose alcohol consumption places them at increased risk of physical, psychological, or 
social complications and who might benefit from brief intervention” (Kaner, Newbury-
Birch & Heather, 2009, p. 198). Opportunities for screening are plentiful in primary care 
and general hospital settings, including new patient registration or intake assessments, 
annual check-ups, or in treatment for certain conditions linked to alcohol use (e.g., 
diabetes or injury) (Kaner, Newbury-Birch & Heather, 2009). Importantly, screening 
does not have to occupy a lengthy amount of time, as most screening measures involve 
paper or electronic questionnaires patients complete while waiting for an appointment. 
Even for patients without any alcohol consumption issues, screening still provides an 
opportunity to educate patients about the beneficial effects of lowering alcohol 
consumption (Barbor & Higgins-Biddle, 2001). 
         Common screening measures include the CAGE Questionnaire (Ewing, 1984), 
Michigan Alcohol Screening Test (MAST; Selzer, 1971), the Alcohol Dependence Scale 
(ADS; Skinner & Allen, 1982), and the Alcohol, Smoking, and Substance Involvement 
Screening Test (ASSIST; Henry-Edwards, Humeniuk, Ali, Poznyak & Monteiro, 2003). 
Perhaps the most commonly used measure is the Alcohol Use Disorders Identification 
Test (AUDIT), developed by the World Health Organization (Barbor, Higgins-Biddle, 
Saunders & Monterio, 2001). The 10-question AUDIT provides an especially sensitive 
tool to identify harmful or hazardous drinkers (see Table 1) and is designed for delivery 
by primary health care workers (Babor et al., 2001). 
         Brief interventions. Broadly speaking, brief interventions may be understood as 
“a spectrum of clinical activity focused on the use of a talk-based therapeutic approach to 
	   
7 
reducing excessive drinking and its associated problems” (Kaner, Newbury-Birch & 
Heather, 2009, p. 201). While the “clinical activity” may vary, the commonality that 
connects brief interventions is their brevity, with most brief interventions composed of 5-
60 minutes of counseling in 3-5 sessions. Another connecting factor is the "FRAMES" 
structure. FRAMES is an acronym for Feedback, Responsibility, Advice, Menu (i.e., 
providing options for change), Empathy and Self-efficacy (Miller & Sanchez, 1993). 
While FRAMES guides many interventions, the structure is not a requirement in order to 
be labeled a "brief intervention."  
         Notably, the goals and outcomes of a brief intervention may vary based on the 
patient’s prior level of consumption. For patients at risk of developing alcohol-related 
problems, but not yet classified as having an AUD, the goal may involve reducing 
drinking to below the recommended levels as opposed to abstinence. For those with an 
AUD, a more intensive treatment beyond the brief intervention will most likely be 
needed. Therefore, the PCP may refer the patient to a form of specialized treatment 
(Fleming & Manwell, 1999). Unfortunately, a majority of patients referred to specialized 
treatment will not independently enroll (Bien, Miller & Tonigan, 1993; Fleming & 
Manwell, 1999). Consequently, the only treatment that an AUD patient may be exposed 
to is the brief intervention delivered by the PCP, further highlighting the importance of 
delivering brief interventions within primary care. 
         Generally, brief interventions are effective. When compared to control conditions, 
brief interventions produced a reduction in hazardous and harmful drinking, as 
demonstrated through multiple systematic reviews and meta-analyses (Agosti, 1995; 
Ballesteros, Duffy, Querejeta, Arino & Gonzalez-Pinto, 2004; Bertholet, Daeppen, 
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Wietlisback, Fleming & Burnand, 2005; Bien, Miller & Tonigan, 1993; Kaner et al. 
2007; Moyer, Finney, Swearingen & Vergun, 2002; Poikolainen, 1999; Whitlock, Polen, 
Green, Orleans & Klein, 2004; Wilk, Jensen & Havinghurst, 1997). Of concern from an 
empirical perspective, especially in reference to previous meta-analyses, is the variability 
of the content delivered within the intervention (Barbor & Higgins-Biddle, 200l; Kaner et 
al., 2009). While some investigations may employ a FRAMES structure, many studies do 
not. For example, simple advice lasting less than ten minutes can constitute a brief 
intervention. However, more intensive motivational counseling sessions may also be 
considered a brief intervention. It therefore becomes necessary to discern between each 
type of brief intervention to determine their efficacy, as combing contradictory brief 
interventions (e.g., advice and motivational interviewing) provides an inaccurate 
representation of brief intervention effectiveness. 
         One specific type of brief intervention that warrants an independent investigation 
is the motivational interview (MI), a type of counseling originally developed to address 
alcohol use problems in an in-patient setting (Miller, 1983). Not only has the application 
of motivational interviewing in a clinical practice been steadily increasing, but 
motivational interviewing based empirical investigations have increased as well. For 
instance, a PsycINFO search from 1990 to 1999 using the simple phrase “motivational 
interviewing,” would yield 35 results, and increase to 352 references for studies 
conducted from 2000 to 2008 (Lundahl, Kunz, Brownell, Tollefson & Burke, 2010). 
From 2008 to 2014, there are now over 1,500 studies utilizing motivational interviewing. 
As the practical and experimental application of MI continues to rise, there is an ever-
growing need for a systematic evaluation of MI. Specifically an evaluation is needed in 
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the pivotal primary care setting, which is an attractive venue for MI use. The 
attractiveness is due in part to MI, and its extension motivational enhancement therapy 
(MET), often requiring fewer sessions than some alternative types of therapy (e.g., 
cognitive behavioral therapy). Fewer sessions give MI and MET an advantage in primary 
care settings, where contact may be relatively limited to a few meetings (Miller, Meyers 
& Tonigan, 1999). The following provides an overview of motivational interviewing and 
the postulated causal mechanisms.    
Motivational Interviewing: Overcoming Ambivalence via an Interpersonal Process 
         Motivational interviewing represents “a client-centered, directive method for 
enhancing intrinsic motivation to change by exploring and resolving ambivalence” 
(Miller & Rollnick, 2002, p. 25). Importantly, MI is said to alter behavior through the 
resolution of ambivalence (Miller & Rollnick, 2002). Ambivalence is present when 
patients hold two opposing attitudes or feelings (Hall, Gibbie & Lubman, 2012). For 
example, a patient recognizing and demonstrating concern for the harmful effects of 
alcohol consumption yet continues to drink, despite pleas from a physician to stop, 
becomes classified as ambivalent (Hall, Gibbie & Lubman, 2012). The provider then 
highlights the discrepancy between the patient’s actual behavior and ideal behavior 
(Miller, 2003). No change can begin to occur, regardless of the target behavior (e.g., 
drink less frequently, routinely take medication, eat more fruits and vegetables), until 
ambivalence is addressed (Miller & Rollnick, 2002). 
         Miller and Rollnick (2002) outline three characteristics that capture the “spirit” of 
MI and illustrate certain characteristics the provider shall embody; the provider is to be 
collaborative, autonomy supporting and evocative. The spirit of motivational 
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interviewing highlights the sharp contrast to the classic addictive counseling approach, 
whereby the counselor acts as the expert actively convincing the patient of the necessity 
for change. Instead, patients are assumed to be the expert on personal experiences, and 
possess a fundamental responsibility to choose the outcome. The provider must recognize 
it is ultimately the choice of the patient to change, and illustrates the provider’s support of 
patient autonomy. In expanding upon the initial definition of MI, Miller and Rollnick 
(2002) offer five principles that direct the application and clinical practice of MI while 
maintaining an embodiment of the “spirit.” The principles of MI are, (a) express 
empathy, (b) develop discrepancy, (c) avoid argumentation, (d) roll with resistance, and 
(e) support self-efficacy (Miller & Rollnick, 2002). 
         A specific employment of motivational interviewing, initially called “The 
Drinkers Check Up” and further applied in Project MATCH as Motivational 
Enhancement Therapy (MET), offers an extension of the typical MI interaction (Miller, 
Sovergein & Krege, 1988). MET incorporates a form of personalized feedback into the 
motivational interview (Miller, 2003). In MET, once an alcohol pre-treatment assessment 
is completed, the results are presented to the patient in a “low key, objective fashion” 
(Miller, 2003, p. 138). The low-key presentation is meant to reduce the potential 
resistance a patient may display, whereby the provider will present the findings and ask, 
“what do you make of this?” (Miller, 2003, p. 138). Typically, after delivering 
assessment feedback, an MI intervention is employed.  
         Regardless if MI or MET is selected, the provider must “elicit from the client and 
reinforce reasons for concern and for change” (Miller, 1996, p. 840). The elicitation is 
often referred to as “change talk,” or having patients verbalize reasons for changing their 
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behavior (Miller & Rollnick, 2002). Change talk predicts patient benefit from MI and is 
advanced as the causal mechanism in MI (Miller & Rollnick, 2002; Moyers, Martin, 
Houck, Christopher & Tonigan, 2009). 
         MI/MET as a communication construct: Potential mechanisms of MI efficacy 
through language. The primary mechanism elucidating why MIs is efficacious focuses 
on the speech of the patient that is in support of behavior change, previously referred to 
as “change talk” (Miller & Rollnick, 2002; Moyers et al., 2009). In the seminal work 
relating change talk (CT) to patient behavioral change, Amrhein, Miller, Yahne, Palmer 
and Fulcher (2003) coded 84 video transcripts of patients enrolled in an MI clinical trial, 
and analyzed and closely attended to patients CT and subsequent health outcomes. 
Important to this particular investigation is the division of CT into two primary subtypes: 
preparatory language and commitment language (Miller, Moyers, Ernst & Amrhein, 
2006). Preparatory language is that which expresses a patient’s desire, ability, reasons 
and needs (DARN; Amrhein et al., 2003; Miller et al., 2006). However, Amrhein et al. 
(2003) were primarily concerned with a patient’s commitment language, both in terms of 
frequency and strength. While the frequency of commitment language purely counts its 
incidence, measuring the strength of commitment language can potentially be more 
illustrative of a patient’s readiness to change. For example, “I will try to stop using” 
versus “There’s no question about quitting this time,” provide vastly different examples 
of dedication to commitment, and contribute differently to the probability that change 
will indeed occur (Amrhein et al., 2003, p. 864). 
         Results indicate that the strength of the commitment language, not the frequency 
of commitment language, predicts behavior change. However, the strength of a patient’s 
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preparatory language was not associated with any positive patient outcomes. Miller, 
Benefield and Tonigan’s (1993) findings, which also failed to determine a significant 
relationship between the frequency of a patient’s change talk and the patient’s behavioral 
outcomes, support the results of this investigation. 
         Therapist language and change talk. Due to the relationship CT shares with 
patient behavioral outcomes, recent scholarship has begun to examine the potential ways 
in which the communication of the practitioner can influence and direct the patient’s 
speech in favor of CT (Daeppen, Bertholet, Gmel, Gaume, 2007; Gaume, Gmel, Faouzi 
& Daeppen, 2008; Gaume, Bertholet, Faouzi, Gmel & Daeppen, 2010; Magill, Gaume, 
Apodaca, Walthers, Mostroleo & Borsari, 2014). Findings indicate that employing MI 
consistent behavior (MICO) (e.g., the expression of empathy, reflective listening) 
associates with an increase in CT (Gaume et al., 2008; Gaume et al., 2010). 
         Moyers et al. (2009) became the first to adjoin these previously separate pathways 
(practitioner’s impact on CT as path 1 and CT impact on health outcomes as path 2) into 
one causal chain, therefore directly linking practitioner’s communication to patient 
behavioral outcomes, accomplished through obtaining therapy recordings and 
corresponding patient outcomes from participants in Project MATCH. 
Therapist è Change Talk è Behavioral Outcomes 
          The frequency of MICO behaviors was found to predict patient’s future drinking 
behaviors, whereby patients paired with practitioners who used more MICO behaviors 
were associated with consuming fewer drinks per week. Reflective listening was found to 
be the strongest MICO behavior in eliciting CT from the patient. This outcome is 
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consistent with Gaume et al. (2010), indicating that reflections may be an influential tool 
in the evocation of CT. 
         However, a central question remains: does the link between change talk and 
health outcomes demonstrate causality? In other words, is change talk a reflection of an 
intrapersonal change, or does change talk induce change? As supported by Vader, 
Walters, Prabhu, Houck and Field, (2010) “it is unknown whether such language is 
merely a marker of some other internal change, or if the language is actually functioning 
as a mechanism of change” (p. 191). Regardless if this question remains unanswered, this 
line of inquiry serves to underscore the pivotal role of communication, language and 
influence to MI.          
MI/MET & Primary care 
         MI and/or MET techniques provide practical interventions in primary care due to 
the focus on resolving ambivalence. Ambivalence about changing alcohol consumption is 
a common problem in health care consultations, with approximately one-third to one-half 
of hazardous or harmful drinkers who are not seeking treatment for alcohol feeling 
ambivalent about changing or engaging in an intervention (Anderson, 1996). MI/MET 
has the potential to be an effective technique to initiate behavior change in primary care 
populations through resolution of this ambivalence. 
         However, studies examining MI and/or MET in primary care settings have found 
both significant and non-significant results. For example, D’Amico, Miles, Stern and 
Meredith (2008) assessed an MI intervention for high-risk youth delivered in a 
community-based, primary care setting. Teens randomly assigned to the MI intervention 
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group and a control group receiving “treatment as usual,” demonstrated no statistically 
significant difference in number of days alcohol was consumed. 
         For MET, Emmen, Schippers, Wollersheim and Blejenberg (2005) examined the 
Dutch Motivational Drinker’s Check Up (DVA), a type of intervention modeled after the 
Drinkers Check Up (aka MET). No significant reduction in self-reported alcohol 
consumption was found between the intervention and control group. Self-reported 
consumption was supported by biological measures (carbohydrate-deficient transferrin), 
where no significance was found between the intervention and control group. However, 
other studies examining MI or MET in primary care settings (Sentf, Polen, Freeborn & 
Hollis, 1997; Maisto et al., 2001; Noknoy, Rangsin, Saengcharnchai, 
Tantibhaedhyangkul & McCambridge, 2010) report significant differences between those 
receiving treatment (MI or MET) and control groups. 
         Due to the variation in significance across various studies, an alternative to 
significance testing ought to be utilized. Measuring the effect size over a relatively large 
number of studies may be more appropriate (Moyer, Finney, Swearingen & Vergun, 
2002). Subsequently, a meta-analytic approach can potentially provide a more powerful 
estimate of how MI/MET performs in a primary care setting. 
MI/MET Meta-Analytic Reviews  
         Previous meta-analyses provide support for MI/MET efficacy as applied to 
various health issues and across a number of contexts. However, the effect size of 
MI/MET appears contingent on the comparison treatment or control. For example, in the 
first meta-analysis examining adaptations of MI, Burke, Arkowitz and Menchola (2003) 
found for studies examining alcohol and drug abuse (k = 8), adaptations of MI had a 
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combined effect size near zero (d = .02) when compared to other active treatments and an 
effect size, d = .25 to .53, when compared to no treatment or a placebo control group. 
         Hettema, Steel and Miller (2005) followed to include 72 studies in a meta-
analysis examining MI over a range of health behaviors (e.g., alcohol, smoking, HIV, 
treatment compliance, gambling, water purification, eating disorders, diet and exercise). 
Of these studies, 32 examined alcohol use, with d values ranging from -0.08 to 3.07. The 
largest effect sizes were seen in studies contrasting MI to no-treatment, a waitlist control, 
education or adding MI to a standard form of treatment. A mean d value of 0.41 for post-
treatment and .26 across all study follow-up points (up to 24 months) demonstrates a 
relatively small effect. However, studies focusing on alcohol abuse had effect sizes 
ranging from d  = 0 to more than 3.0. Lundahl and Burke (2009) note that results from 
this particular meta-analysis may be limited, since studies were included that did not 
isolate the effect of MI (e.g., a combination of MI and cognitive behavioral therapy 
(CBT) was compared to a control group who received no treatment.). 
         Vasilaki, Hosier and Cox’s (2006) meta-analysis specifically examined MI and 
alcohol consumption. MI interventions were examined in a variety of contexts across 15 
studies (n=2767) and found that compared to no treatment, MI had a benefit, with d = 
0.18 (95% CI [0.07, 0.29]). Compared to other treatments, d = 0.43 (95% CI [0.17, 
0.70]). 
         Lundahl, Kunz, Brownell, Tollefson and Burke (2010) was the first meta-analysis 
to include studies focusing on MET along with those using MI, producing an average 
effect size of g = .22 (95% CI [0.17, 0.27]) across 132 comparisons. Hedge’s g was 
selected for this particular investigation due to its ability to correct for potential bias as a 
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result of a small sample size, and may be interpreted using Cohen's (1988) convention as 
small (0.2), medium (0.5), and large (0.8) effect sizes (Cooper & Hedges, 1994; 
Hofmann, Sawyer, Witt & Oh, 2010; Lipsey & Wilson, 2001). While Lundahl et al., 
(2010) did not report the precise formula used to calculate g, Hedges & Olkin propose the 
following: g = d (1 – (3/4(n1+n2) – 9)) (p. 81). For alcohol related studies, where 
MI/MET was compared to a weak condition, g = .20. However, when compared to a 
strong comparison group, g = .03. Across all conditions, Lundahl et al., (2010) found that 
MET (g = .32, 95% CI [0.23, 0.40]) is relatively more effective than MI (g = 0.19, 95% 
CI [0.11, 0.27]). However, Lundahl et al., (2013) uncovered no substantial advantage in 
offering MET (d = .321) relative to MI (d = .105) 
         In the most recent meta-analysis and systematic review, VanBuskirk and 
Wetherell (2014) examined the effectiveness of motivational interviewing in primary care 
populations. While this review has the potential to answer the question of efficacy for MI 
in primary care, there are two primary issues. First, duel-focused interventions (e.g., 
cognitive behavioral therapy paired with MI) were included. Therefore, the effect of MI 
cannot be isolated. Second, participant recruitment was required to occur in a primary 
care setting, although the intervention could be delivered outside of a primary care 
setting. Subsequently, studies were included if they used telephone-based or other 
mediated forms of delivery. Arguably, the combination of these two factors does not 
provide an accurate picture of MI in a primary care setting. 
Active vs. Passive Treatment Seeking and Implications For Meta-Analyses 
          The results of past meta-analyses support the viability of MI/MET as a treatment 
option. However, a problem plagues previous MI/MET meta-analyses and confounds 
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actual effect sizes is the practice of combining studies examining two distinct populations 
(Heather, 1995, 1996). The first population includes those identified opportunistically 
through primary care and who are subsequently not seeking treatment for alcohol 
(Heather, 1995; Moyer et al., 2002). The second are those who are actively seeking 
alcohol treatment, and are thus more motivated to change. As shown in Table 2, the 
majority of MI based meta-analyses have combined treatment seeking and non-treatment 
seeking populations. Combining non-treatment seeking patients with those who are 
seeking treatment may inflate the reported effect of MI/MET, due to important 
differences between the level of motivation and readiness to change (Heather, 1995). 
Treating all populations as homogeneous will not present an accurate picture of the 
efficacy of MI/MET. Given the opportunity primary care can provide, it is important to 
determine the utility of MI/MET in non-treatment seeking, primary care populations.  
         A second problem arises when the effects of MI and MET are combined to create 
the overall effect size. This does not allow for the separation and isolation of MI/MET 
and the different components of each type of intervention. According to Burke, Arkowitz 
and Dunn (2002) “an immediate task for research is to dismantle feedback based AMIs 
(adaption of motivational interviewing) [i.e., MET] into their main components-problem 
feedback and motivational interviewing- to determine their relative contributions to 
outcome” (p. 244). 
         Thus far, Lundahl et al. (2010) and Lundhal et al. (2013) are the only meta-
analyses to discern between the delivery of MI and MET. However, one meta-analysis 
found a relative difference (Lundahl et al., 2010) while the other did not (Lundahl et al., 
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2013). Furthermore, it remains unknown if the feedback provided in MET provides any 
additional benefit within a primary care population. 
         Accordingly, this meta-analysis seeks to answer the following inquires: 
RQ 1: What is the effect size of MI and MET as an alcohol intervention in primary care 
and general health care settings? 
RQ 2: Is there a difference in effect size between MI and MET in primary care 
 populations? 
Method 
Literature Search 
         A comprehensive search strategy was performed in order to collect all pertinent 
studies. This consisted of searching (a) electronic databases, (b) previous meta-analyses 
and systematic reviews, and (c) the bibliographic resource provided by the Motivational 
Interviewing Network of Trainers (MINT). 
         First, 17 electronic databases (ABI/INFORM, Alcohol and Alcohol Problems 
Science Database (ETOH), CINAHL Plus, Cochrane Trials, Cochrane Drug and Alcohol 
and Effective Practice and Organization of Care specialized register, CommAbstracts, 
Communication and Mass Media Complete, ERIC, ProQuest Dissertation and Theses 
Global, PsychINFO/PsychLit, PsychArticles, PubMed/Medline, Science Citation Index 
and Social Science Citation Index (via Web Of Science), ScienceDirect/ISI, Sociological 
Abstracts) were searched, with the last search performed in February of 2015. 
         Database searching was performed using a Boolean search strategy with the 
following terms: (motivational interviewing OR motivational enhancement therapy OR 
drinkers check up OR motivational intervention) AND (primary care OR general practice 
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OR community health care) AND (alcohol OR alcohol consumption OR drinking OR 
alcohol use OR hazardous drinking). 
         Secondary searching was executed by hand searching the reference lists from 
previous meta-analyses or systematic reviews addressing either motivational interviewing 
or brief interventions (Bertholet, Daeppen, Wietlisbach, Fleming, Burnand, 2005; Beich, 
Thorsen & Rollnick, 2003; Bien, Miller & Tonigan, 1993; Burke et al., 2003; Burke, 
Dunn, Atkins & Phelps, 2004; Carey, Scott-Sheldon, Elliott, Garey & Carey, 2012; 
Dunn, Deroo & Rivara, 2001; Emmen, Schippers, Bleigenberg & Wollersheim, 2004; 
Hettema et al., 2004; Jensen, Cushing, Aylward, Craig, Sorell & Steele, 2011; Kahan, 
Wilson & Becker, 1995; Kaner et al., 2007; Lundahl et al., 2010; Lundahl et al., 2013; 
Moyer, Finney, Swearingen & Vergun, 2002; Noonan & Moyers, 1997; Poikolainen, 
1999; Rubak et al., 2005; Smedslund Berg, Hammerstrom, Steiro, Leiknes, Dahl, 
Karlsen, 2011; Vasilaki et al., 2006; VanBuskirk & Wetherell, 2014; Wilk, Jensen & 
Havighurst, 1997). 
         Finally, the Motivational Interviewing Network of Trainers 1,290 bibliographic 
entries (http://www.motivationalinterviewing.org/bibliography?s=author&o=asc) were 
searched, with a focus on locating relevant key words within the title of the entry.   
Study Eligibility                                                                                                                 
Studies were included if the author(s); 
(a) Used MI or MET as a primary technique of intervention; 
(b) Used a randomized control trial design. Acceptable control groups include 
treatment as usual, information only control, waitlist control, or assessment only control; 
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(c) Isolated the impact of MI or MET, especially if it was used as an additive 
component to treatment; 
(d) Delivered the intervention in a general medical setting. This is operationalized 
as a health care facility in which patients may seek care for a variety of health problems 
and access is not the result of a referral (Kaner et al., 2007). Common settings may 
include a general hospital, stand alone primary care clinics, and clinics within a hospital. 
         Studies were excluded if patients were actively seeking a consultation for alcohol 
problems or addiction (as opposed to seeking help for a different or general medical 
condition), were recruited in non-clinical or health care related settings (e.g., university 
classes) or through advertisements, were diagnosed with concurrent psychosis (e.g., 
schizophrenia) or were admitted to a psychiatric inpatient program. In addition, studies 
were excluded if patients were mandated to treatment (e.g., court ordered rehabilitation, 
counseling required as a result of university alcohol policy violation), were incarcerated, 
or currently in a separate substance abuse treatment. 
         Certain methodological considerations also made a study ineligible for inclusion, 
including studies in which MI/MET was delivered exclusively through computer-based 
programs, telephone interviews or mailings (i.e., MI/MET not delivered by humans), if 
there was no measure of alcohol consumption or alcohol related problems, or the article 
was published before 1983, as MI was not introduced until this date. 
Coding of Studies 
 Dependent outcomes. The following outcomes were synthesized from relevant 
studies (a) Patient scores on drinking measures (e.g., AUDIT, ASSIST), (b) Biological 
measures (e.g., GGT, CDT), (c) Heavy drinking or binge drinking episodes (commonly 
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operationalized as 5 or more drinks per occasion for men and 4 or more drinks per 
occasion for women), (d) Total consumption (commonly measured as alcohol by volume 
or standardized ethanol content), (e) Drinking days or occasions, (f) Any alcohol use 
(particularly relevant in studies with a sample of pregnant women), (g) Abstinence, (h) 
Hazardous or risky use (as indicated by study author, and typically operationalized 
following WHO guidelines; see Table 1), (i) Drinks per drinking occasion, (j) Alcohol 
consequences (typically measured using alcohol related harm validated measures, 
including the Rutgers Alcohol Problem Index (RAPI; White and Labouvie, 1989) and the 
Drinker Inventory of Consequences-2L (DrInC-2L; Miller, Tonnigan & Longabaugh, 
1995),  (k) Quality of life, and (l) Alcohol dependence or abuse.  
 Moderator Variables. The following articles were coded in order to identify 
potential factors that influence the efficacy of MI/MET and MI/MET delivery: 
(a) Type of control group. 
(b) Type of MI (as described by study author). 
(c) For those who delivered the intervention (i.e., interventionists): 
         (1) Amount of MI training (in hours). 
         (2) Fidelity to MI intervention (when provided by authors, how accurately 
providers delivered MI/MET and how this was measured. For example, if fidelity was 
measured via audio or video recording, was it assessed with or without a standardized 
system (e.g., the MI Skill Code (MISC), Miller, 2002). 
         (3) Educational background. 
(d) Screening measurement employed and subsequent study eligibility based on screening 
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(e) If provided, type or intensity of patient alcohol use disorder prior to intervention, 
based on screening criteria. 
(f) Patient exposure to MI delivery (total number of time spent (in minutes) in sessions in 
which MI/MET was delivered, not including assessments). 
(g) Number of sessions whereby MI was delivered. 
(h) If patients with alcohol dependence were excluded from the study. 
(i) Role of MI in treatment (Additive: was combined with another treatment, but effect of 
MI/MET isolated, Prelude: MI/MET used before more intensive treatment, yet effect of 
MI/MET isolated, or Stand Alone: MI/MET was the sole treatment provided). 
(j) Durability of MI treatment (the longest time period in which post-intervention 
measures were collected).      
Statistical Analysis 
 Conversion. d was used as the primary effect size in this review. According to 
Durlak (1995), when a meta-analysis is evaluating some form of treatment “the most 
important variables is the standardized difference between group means” (p. 327). This 
difference, called Cohen’s d, is the most “widely used statistic in the meta-analysis of 
experimental or intervention studies” (Hunter & Schmidt, 2004, p. 246) and is commonly 
applied “when the research in question is related to group differences” (Whinston & Li, 
2011, p. 274). d is calculated by subtracting the control group mean from the intervention 
group mean and dividing by the pooled standard deviation (Hedges & Olkin, 1985). 
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deviation (Hedges & Olkin, 1985; Shavelson, 1996; Wolf,
1986). Effect sizes most commonly used in the behavioral
sciences re Gla s’s Δ, Cohen’s d, and Hedges’s g. The
main difference between Glass’s Δ and Cohen’s d is the
standar  deviation us d in the denominat r. Glass’s Δ uses
the standard deviation of the control group to standardize
the mean difference between the in erventio  and control
groups, as shown in Formula 3:
Cohen’s d uses the weighted average of the standard
deviations of both groups to standardize the mean differ-
ence between the intervention and control groups, as shown
in Formula 4.
The main difference between Cohen’s d and Hedges’s g
is that the latter is multiplied by a correction factor for
small samples.
Formula 5 shows that Hedges’s g is actually Cohen’s d—
which uses the pooled standard deviations of both groups
in the denominator—with a correction factor for use with
small sample sizes. For example, to compute Cohen’s d,
using the data from the James (1976) study (see Table 1):
This d index in the form of Glass’s Δ says that the TO
intervention caused a 1.43 SD increase in SPM. In other
words, PWS in the intervention group spoke more SPM
than did those in the control group. Notice that the result is
reported in standard deviation units because the mean
difference between the two groups was divided by the
control group standard deviation. However, the standard
deviation for the control group is three times smaller than
that for the TO group. When the standard deviations for
both groups are combined through Cohen’s d, the effect
size becomes:
This d index in the form of Cohen’s d says that the TO
intervention caused a 0.60 SD increase in SPM. Notice that
Glass’s Δ is more than twice the size of Cohen’s d because
of the smaller standard deviation used to standardized
Glass’s Δ. Notice also that causal language is used to
describe the effect of the TO intervention. Attaching a
causal interpretation to the effect size is not because of
anything inherent in the effect size itself. Rather, the causal
interpretation of the effect is possible because study
participants were randomly assigned to the TO and control
groups (Boruch, 1997; Campbell & Stanley, 1963; Fried-
man, Furberg, & Demets, 1998; Mosteller & Boruch, 2002).
In practice, Cohen’s d is used more often than Glass’s Δ.
However, when the combined sample sizes for the interven-
tion and control groups are less than or equal to 20 (n ≤
20), Cohen’s d is an upwardly biased estimator of the
effect size in the population (δ) (Hedges & Olkin, 1985;
Hedges et al., 1989). In other words, Cohen’s d tends to
overestimate an intervention’s effect in small samples. To
correct for the upward bias in Cohen’s d, use Hedges’s g
(by applying Formula 5) as follows:
The effect size estimated using Hedges’s g (0.57) is
smaller than the effect size that was estimated using
Cohen’s d because Hedges’s g corrects for the upward bias
that arises in Cohen’s d when estimated in small samples.
In practice, Hedges’s g can be used in both large and small
samples to avoid having to switch between Hedges’s g and
Cohen’s d when a systematic review includes some studies
that have small samples and others that have large samples
(Chalmers & Altman, 1995). It has been demonstrated that
Hedges’s g converges to Cohen’s d in large samples where
n > 20 (Hedges & Olkin, 1985; Hunter & Schmidt, 2004;
Kline, 2004; Lipsey & Wilson, 2001). Like Cohen’s d,
Hedges’s g has the following properties:
• It indexes the difference between the mean of the
intervention group and the mean of the control group.
• It can be positive or negative.
• It is interpreted as a z score in standard deviation
units. However, it should be noted that individual
effect sizes are not part of the z score distribution
(i.e., they will not sum to zero).
Recommendations for
Clinicians and Practitioners
An effect size, as the name implies, conveys an estimate of
the relative effect of an intervention. Use of the effect size
has grown significantly during the past three decades.
Clinicians and practitioners who are interested in what
works in speech and communication disorders should
consider the APA Task Force’s endorsement of the effect
size and incorporate its use into their clinical work and
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XI – XCCohen’s d =(4)
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 When calculating between group differences for all relevant variables, the mean 
and standard deviation of each variable was compared to the mean and standard 
deviation of the control condition at all follow up points. 
         Ninety-five percent confidence intervals were calculated from their variance using 
the following estimation (Hedges and Olkin, 1985, p. 86). 
σ2 (d) = [(nE + nc )/nEnc ] + [d2/2 (nE + nc)] 
Where nE is the sample size of the experimental group and nc is the sample size of the 
control group. 
 If mean, standard deviation or sample size information were missing, effect sizes 
were calculated by converting significance testing (e.g., F, t, chi-square) to r and then 
converting r to d using the following equation (Hunter & Schmidt, 2004, p. 279). 
 
 The mean effect size was calculated by dividing the sum of the n-weighted effects 
by the sum of the sample. 
 Corrections for Artifact. All effects were corrected for error in measurement 
(i.e., correction for attenuation) using reported reliability coefficients (Hunter & Schmidt, 
2004). When primary investigations failed to report reliability coefficients for measures 
(e.g., ASSIST, AUDIT), effects were corrected using previously reported reliability 
coefficients (see Allen, Litten, Fertig, & Babor, 1997). When self-reported drinking 
behaviors, such as total consumption or drinking days/occasions, were measured using a 
timeline follow back drinking (TLFB) procedure, corrections were based on reliability as 
reported by Sobell, Sobell, Leo and Cancilla (1988).   
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 Outlier Identification. The selection criteria yielded 34 studies. For article 
screening and exclusion process, please refer to the PRISMA Flow Chart (Fig. 1). The 34 
studies resulted in 185 effect size calculations. However, 25 outliers were removed, thus 
resulting in 160 effects used in analysis. Outliers were operationalized as those effects 
falling 5 SDs below the mean or 5 SDs above the mean, and were identified through z-
standardization of all effect sizes. Primary justifications for removal of outliers was based 
on certain sample populations potentially having an increased motivation to decrease or 
cease drinking (e.g., pregnant women; Osterman & Dyehouse, 2012), and thus 
contributed to an inflated effect size. Patients with medical conditions where alcohol is 
strongly contraindicated had a more dramatic decrease in alcohol consumption, and 
resulted in larger mean differences compared to a typical patient population. Weinrieb, 
Van Horn, Lynch and Lucey’s (2011) study had all calculated effect sizes outside 5 SDs 
of outcome means and was thus removed from analysis. Within this investigation, the 
population sampled was composed of patients undergoing a liver transplant as a result of 
alcohol related liver disease. In order for their liver transplant to be successful, those with 
prior liver cirrhosis must completely abstain from alcohol (NIAAA, 2005). Due to the 
elimination of Weinrieb et al. (2011), the final number of studies utilized in this 
investigation is 33 (see Table 3 for study characteristics).  
 
Results  
Overall Effect Sizes 
 The average effect of MI and/or MET indicates a small improvement in relevant 
drinking outcomes (𝑑 = .153, 95% CI [0.109, 0.196], k = 33, N = 32,588). This is, 
however, based on a heterogeneous set of findings, χ2 = 585.8 (159, N = 32,588), p < .05.  
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 Scores on Drinking Measures. The average effect of MI and/or MET on the 
reduction of patient scores on drinking measures (e.g., ASSIST, AUDIT) was very small (𝑑 = .038, 95% CI [-0.055, 0.131], N= 2903) based on a heterogeneous set of results, χ2 
= 57.7 (5, N = 2903), p < .05.  
 Biological Measures. The average effect of MI and/or MET on the reduction of 
alcohol biological measures (e.g., GGT, CDT) was small (𝑑 = .218, 95% CI [0.012, 
0.423], N = 767) based on a heterogeneous set of results, χ2 = 17.71 (6, N = 767), p < .05. 
 Heavy Drinking or Binge Drinking Episodes. The average effect of MI and/or 
MET on the reduction of alcohol heavy or binge drinking episodes was small (𝑑 = .181, 
95% CI [0.01, 0.262], N = 7067) based on a heterogeneous set of results, χ2 = 150.46 (35, 
N = 7067), p < .05.  
 Total Consumption. The average effect of MI and/or MET on the reduction of 
total alcohol consumption was small (𝑑 = .175, 95% CI [0.116, 0.234] N = 6796) based 
on a heterogeneous set of results, χ2 = 104.16 (32, N = 6796), p < .05. 
 Drinking Days or Occasions. The average effect of MI and/or MET on the 
reduction of total drinking days or occasions was positive (𝑑 = .299, 95% CI [0.135, 
0.462], N = 1072), based on a homogeneous set of results, χ2 = 5.43 (6, N = 1072), p > 
.05.  
 Any Alcohol Use. The average effect of MI and/or MET on patient use of any 
alcohol products was positive (𝑑 = .304, 95% CI [0.076, 0.532], N = 804) based on a 
heterogeneous set of results χ2 = 8.07 (3, N = 804), p < .05. 
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 Abstinence. The average effect of MI and/or MET on patient abstinence was 
small (𝑑  = .136, 95% CI [-0.005, 0.277], N = 1204), based on a homogeneous set of 
results, χ2 = 4.69 (6, N =1204), p > .05.  
 Hazardous or At-Risk Use. The average effect of MI and/or MET on patient 
reduction of hazardous or at risk alcohol use was small (𝑑  = .198, 95% CI [0.092, 0.3], N 
=1503) based on a heterogeneous set of results, χ2 = 14.72 (5, N =1503), p < .05. 
 Drinks per Drinking Occasion. The average effect of MI and/or MET on 
reduction of drinks per drinking occasion was small (𝑑 = .179, 95% CI [0.055, 0.303], N 
= 2725) based on a heterogeneous set of results, χ2 = 41.31 (14, N = 2725), p < .05. 
 Alcohol Consequences. The average effect of MI and/or MET on patient alcohol 
consequences was small (𝑑 = .125, 95% CI [-0.004, 0.254], N = 4663) based on a 
homogeneous set of results, χ2 = 34.99 (28, N = 4663), p > .05.   
 Quality of Life. The average effect of MI and/or MET on improvement of quality 
of life was very small (𝑑 = .071, 95% CI [-0.096, 0.238], N = 1964) based on a 
homogeneous set of results, χ2 = 5.82 (4, N = 1964), p > .05. 
 Alcohol Dependence or Abuse. The average effect of MI and/or MET on patient 
reduction of alcohol dependence or abuse was extremely small (𝑑 = -.001, 95% CI [-
0.169, 0.167], N = 1120), and negative, and thus indicates a very small increase in 
frequency of alcohol or abuse. This is based on a homogeneous set of results, χ2 = 2.84 
(2, N = 1120), p > .05. 
Durability of MI and MET 
 For follow up points ranging from 4 to 12 months, the average effect of MI/MET 
was small (𝑑 = .165, N = 11,101). However, the effect increased slightly at follow up 
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assessments occurring from 16 to 24 weeks  (𝑑   = .19, N = 9,745). For those follow up 
points exceeding 24 weeks (25, 36 and 52 weeks), the average affect was relatively small (𝑑 = .11, N = 11,708). 
MI vs. MET  
 The relative benefit of offering MET as opposed to MI was minute, with an 
average effect of MI = .114, (95% CI [0.06, 0.016], N = 8689) compared to 𝑑 =  .125, 
(95% CI [0.044, 0.206], N = 21,226) for MET, thus demonstrating no significant benefit 
in offering feedback to patients in primary care settings.  
Discussion 
 This meta-analysis documents how MI and/or MET performs in primary and 
general health care settings for the purpose of alcohol reduction. Results suggest that MI 
and/or MET exerts a small, positive overall effect (𝑑 = .153). However, the overall effect 
of MI is smaller than those from comparable MI/MET focused meta-analyses. For 
instance, VanBuskirk and Wetherell (2014) uncovered 𝑑 = .22 (95% CI [-.21, .65]) for 
general substance abuse treatment within opportunistic health care. Within this 
investigation, MI/MET demonstrates a small, positive effect for most alcohol related 
variables, including biological measures (𝑑 = .218), binge drinking episodes (𝑑 = .181), 
total consumption (𝑑 = .175), drinking days/occasions (𝑑 = .299), alcohol use of any kind 
(𝑑 = .304), hazardous/at-risk use (𝑑 = .198), drinks per drinking occasion (𝑑 = .179), and 
alcohol related consequences (𝑑 = .125). Like the overall effect of MI/MET, certain 
outcome variables had substantially smaller effects compared to other investigations. For 
example, in the review by Burke et al., (2003), the average effect of MI on peak blood 
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alcohol concentration (BAC) was 𝑑  = .53, as opposed to this investigation where 𝑑 = 
.181 for similar intoxication measures.  
 Interestingly, no significant benefit in offering MET (i.e., MI + Feedback) as 
opposed to MI existed. The lack of MET to MI benefit appears surprising considering the 
results of Project MATCH (1997, 1998) reporting MET to be just as effective as more 
intensive and time consuming forms of treatment, such as cognitive behavioral therapy. 
Lundahl et al., (2010) corroborates the finding with an investigation concluding 
significantly better health outcomes in offering MET as opposed to MI. Future 
investigations should explore why feedback exerts no profound increase on the positive 
outcomes of MI in primary and general health care settings.  
 A common finding in investigations examining discrete interventions (i.e., one on 
one therapeutic sessions) involves the gradual decay of effectiveness. However, MI-based 
investigations often show no such relapse (see Burke et al., 2003; Dunn et al., 2001). 
MI/MET exerted a relatively stable impact over time, with the effect of MI/MET at 25 to 
32 weeks (𝑑 = .110) relatively similar to the effect at 4 to 12 weeks (𝑑 = .165). This 
result is consistent with previous meta-analyses and represents a relatively short-term 
effect. Long-term stability past one year could not be assessed because no study included 
in this meta-analysis followed patients beyond 52 weeks.  
Limitations 
  Nearly all studies included in this investigation fail to conceal allocation or use 
blind assignment. However, concealment and blind assignment may be difficult in RCTs 
examining interventions in human populations; particularly when informed consent 
procedures stipulate noticeable differences between experimental and control conditions. 
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 Importantly, given the heterogeneity of most study outcomes, follow up 
moderator analyses are appropriate and necessary. Even though all studies focused on 
excessive alcohol consumption, high variability across studies still exists. This variability 
is speculated to be a result of two potential factors. The first is inconsistency in the 
amount of time MI/MET was delivered. For instance, the minimum time of intervention 
delivery was 10 minutes across one session (Mertens, Ward, Bresick, Broder, & Weisner, 
2014). The maximum was 150 minutes across 5 sessions (Rubio et al., 2014). 
 The second source of variability may be attributed to discrepancies in clinical 
delivery of MI/MET. While a majority of the studies indicate the length of interventionist 
training (typically described in terms of days of training), others simply stated that 
practitioners had “extensive training.” In addition, few studies detail the precise training 
received by the interventionists. Second, 22 of the 33 investigations indicate that fidelity 
to MI/MET was assessed in some manner, most often through a review of audio and 
videotapes. However, only seven of these studies used a standardized fidelity assessment 
(e.g., Motivational Interviewing Skill Code, Motivational Interviewing Treatment 
Integrity). For the purpose of determining relevant constructs that contribute to variability 
across studies, follow-up analyses are required. Therefore, a strong limitation of this 
meta-analysis stems from the reliance on primary studies that may lack consistency in 
treatment application. Subsequently, findings must be interpreted with a degree of 
caution.  
Comparative Efficacy of MI/MET and Clinical Relevance 
 In order to determine the efficacy of MI/MET relative to other viable therapies 
requires a brief review. Lipsey and Wilson (1993) collected meta-analytic comparative 
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data for psychological, educational, and behavioral treatments and interventions. Through 
calculating a distribution of mean effect sizes (d), it was discovered that interventions 
produced a mean and median effect sizes around .5 (SD = .29). The average effect size of 
this investigation (𝑑 = .153) is outside one standard deviation of the mean effect of 
determined by Lipsey and Wilson (1993). Arguably, the effect of MI within primary and 
general health care may be inconsistent with other interventions in more specialized 
settings.    
 However, MI/MET compared to other brief interventions delivered in primary 
care is more aligned with the results of this investigation. Moyer, Finney, Swearingen and 
Vergun (2002) examined brief intervention efficacy for alcohol problems in both 
treatment seeking and non-treatment seeking populations, and is thus considered a 
comparable reference. For non-treatment seeking populations, the effect of brief 
interventions at 3 to 6 months g = .144, 6 to 12 months g = .241 and 12+ months g = 
.129, respectively. This is similar to the longitudinal effects uncovered in this meta-
analysis, and may indicate that MI/MET is more comparable in effectiveness to brief 
interventions than previously thought.  
 As MI/MET may potentially be less effective in primary care as opposed to other 
health care settings, the decision to implement MI/MET within a specific clinic must be 
carefully considered. The choice to adopt a particular intervention is highly dependent on 
certain relevant issues, and must be weighed against factors such as cost effectiveness, 
ease of learning, time of delivery and typical patient populations. Importantly, the 
decision should ultimately rest on the confidence a practitioner feels in delivering MI 
and/or MET. Confidence may reflect MI training, but may also depend on the character 
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and predispositions of the practitioner. MI/MET is contingent upon the expression of 
empathy, reflective listening and non-confrontational communication. A PCP feeling 
uneasy about embracing a patient-centered perspective should considering adopting a 
different intervention framework, as there are other effective interventions to choose 
from.  
Conclusion 
 Due to the significant role primary health care serves in reducing excessive 
alcohol consumption, it becomes increasingly crucial to assess potentially efficacious 
interventions that can be delivered within this setting. However, primary care patients are 
especially ambivalent about changing their alcohol related behaviors, particularly when 
they are not actively seeking treatment for problematic alcohol consumption. MI and 
MET are two analogous therapeutic styles which focus on reducing patient ambivalence 
through shifting patient language in favor of behavior change. This investigation 
examined MI and MET in primary care settings through a meta-analytic approach in 
order to determine the efficacy of MI and/or MET within this important context.   
 MI and MET were found to exert a small, positive and relatively stable effect on 
patient alcohol related outcomes within primary and general health care. The largest 
benefit was seen in patients who sought to eliminate all alcohol use, as opposed to 
moderate consumption. Interestingly, adding feedback did not considerably improve 
patient outcomes. Currently, no studies have reported MI or MET as producing any 
adverse effects. Therefore, it may be reasonably assumed that MI/MET produces a small 
benefit in primary care with few risks. Ultimately, if a PCP feels comfortable delivering 
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MI or MET, they can be reasonably assured that MI/MET will be more effective than 
delivering no intervention.  
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Table 1 
 
Alcohol Consumption Definitions  
Term Definition 
Alcohol Use Disorder a A problematic pattern of alcohol use leading to clinically 
significant impairment or distress, as manifested by at least two 
of the following, occurring within a 12 month period 
1. Alcohol is often taken in larger amounts and over a longer 
period of time than was intended 
2. There is a persistent desire or unsuccessful efforts to cut 
down or control alcohol use 
3. A great deal of time is spent in activities necessary to obtain, 
use, or recover from alcohol 
4. Craving, or a strong desire or urge to use alcohol 
5. Recurrent alcohol use resulting in a failure to fulfill major 
role obligations at work, school or home 
6. Continued alcohol use despite having persistent or recurrent 
social or interpersonal problems cause or exacerbated by the 
effects of alcohol  
7. Important social, occupational or recreational activities are 
given up or reduced because of alcohol 
8. Recurrent alcohol use in situations in which it is physically 
hazardous 
9. Alcohol use is continued despite knowledge of having a 
persistent or recurrent physical or psychological problem that is 
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likely to have been caused or exacerbated by alcohol 
10. Tolerance to alcohol (e.g., a need for markedly increased 
amount to achieve intoxication) 
11. Withdrawal from alcohol as defined by DSM-V 
Mild Alcohol Use Disorder: Presence of 2-3 symptoms 
Moderate Alcohol Use Disorder: Presence of 4-5 symptoms 
Severe Alcohol Use Disorder: Presence of 6 or more 
symptoms 
Binge Drinking d A pattern of drinking that brings blood alcohol concentration 
(BAC) levels to 0.08 g/dL. This typically occurs after 4 drinks 
for women and 5 drinks for men—in about 2 hours. 
Excessive Drinking/ 
Consumption b, c 
Includes binge drinking, heavy drinking, any alcohol use by 
people under the age of 21 (United States legal drinking age), 
and any alcohol use by pregnant women  
Harmful Use a, e 
 
A pattern of psychoactive substance use that is causing damage 
to health. The damage may be physical (as in cases of hepatitis 
from the self-administration of injected drugs) or mental (e.g. 
episodes of depressive disorder secondary to heavy 
consumption of alcohol). Harmful use commonly, but not 
invariably, has adverse social consequences 
Hazardous Use e A pattern of substance abuse that increases the risks of harmful 
consequences for the user, and a pattern of drinking that is of 
public health significance despite absence of any current 
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disorder in the individual user 
Heavy Drinking c,e A pattern of drinking that exceeds some standard of moderate 
drinking or defined threshold, i.e., for women, 8 or more drinks 
per week. For men, 15 or more drinks per week. 
a American Psychological Association (APA; 2013). b Centers for Disease Control and 
Prevention, (2014a). c Centers for Disease Control and Prevention, (2014b). d National 
Institute on Alcohol Abuse and Alcoholism, (n.d.).e World Health Organization, (1994). 
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Table 2 
 
Previous Motivational Interviewing Meta-Analyses Characteristics 
 
Study (by first 
author) 
Health 
behaviors 
addressed 
Setting(s) MI or MET 
isolated from 
other active 
treatments? 
Combination of 
treatment and 
non-treatment 
seeking patients?  
Burke (2003) Variety All Yes Yes 
Hettema (2005) Variety All No Yes 
Vasilaki (2006) Alcohol All Yes Yes 
Lundahl (2010) Variety All Yes Yes 
Lundahl (2013) Variety All Yes No 
VanBuskirk (2014) Variety Primary Care No Yes 
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Table 3 
 
Selected Study Characteristics 
Study (by first author) Sample Sessions Dose 
 (In Minutes) 
Final Follow 
Up Point (In 
Weeks) 
Allen (2013) N = 370 
F; 0% 
4 to 6 Not indicated 52 
Beckham (2003, 2007) N = 26 
F; 53% 
1 45-60 6 
Butler (2013) N = 1401 
F; Not 
indicated 
Not indicated Not indicated 52 
Daeppen (2011) N = 371 
F; 0% 
1 15 24 
D’Amico (2008) N = 42 
F; 52.4% 
2 20-30 12 
Dieperink (2014) N = 120 
F; 5% 
4 120-180 25 
Dimeff (1997) N = 33 
F; 60% 
5 100 4 
Drummond (2009) N = 90 
F; 0% 
1 to 5 40-200 24 
Emmen (2005) N = 112 
F; 24% 
1 60 24 
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Freyer-Adam (2008) N = 515 
F; 6% 
1 25 52 
Gaume (2014) N = 50 
F; 0% 
1 20-30 12 
Gillham (2010) N =50 
F; 71% 
Not indicated Not indicated 12 
Handmaker (1999) N = 34 
F; 100% 
1 60 8 
Hansen (2011) N = 616 
F; 48.8% 
1 10 52 
Hasin (2013) N = 165 
F; 21.8% 
3 40-55 8 
Heather (1996) N = 80 
F; 0% 
1 30-40 24 
Humeniuk (2012) N = 631 
F; 28% 
1 13.8 25 
Kuchipudi (1990) N = 114 
F; not 
indicated 
5 45-75 10-16 
Maisto (2001) N = 158 
F; 30% 
3 60-85 52 
McDevitt-Murphy 
(2014) 
N = 63 
F; 8.8% 
1 60 24 
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Mertens (2014) N = 363 
F; 52% 
1 10 12 
Naar-King (2006) N = 51 
F; 48% 
4 240 12 
Noknoy (2010) N = 107 
F; 9% 
1 10 24 
Osterman (2012) N = 56 
F; 100% 
1 30 24 
Reiff-Hekking (2005) N = 445 
F; 37% 
1 5-10 52 
Rendall-Mkosi (2013) N = 125 
F; 100% 
5 Not indicated 52 
Rubio (2014) N = 251 
F; 100% 
5 50-150 6 weeks 
postpartum 
Saitz (2007) N = 287 
F; 29% 
1 30 52 
Saitz (2014) N = 346 
F; 30% 
2 50-75 24 
Satre (2013) N = 97 
F; 64.4% 
3 75 24 
Schaus (2009) N = 236 
F; 52% 
2 40 52 
Senft (1997) N = 411 1 15 52 
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F; 30% 
Watson (2013) N = 463 
F; 20% 
1 to 4 20-120 52 
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Table 4 
 
Average Effect Sizes For Outcome Variables  
 
Outcome 𝑑 95% CI χ2 df 
Scores on Drinking Measures 0.038 0.055, 0.131 57.7* 5 
Biological Measures 0.218 0.012, 0.423 17.71* 6 
Heavy Drinking/Binge Drinking  0.181 0.01, 0.262 150.46* 35 
Total Consumption 0.175 0.116, 0.234 104.16* 32 
Drinking Days/Occasions 0.299 0.135, 0.462 5.43 6 
Any Alcohol Use 0.304 0.076, 0.532 8.07* 3 
Abstinence 0.136 -0.005, 0.277 4.69 6 
Hazardous/At Risk Use 0.198 0.092, 0.3 14.72* 5 
Drinks per Drinking Occasion  0.179 0.055, 0.303 41.31* 14 
Alcohol Consequences 0.125 -0.004, 0.254 34.99 28 
Quality of Life 0.071 -0.096, 0.238 5.82 4 
Alcohol Dependence/Abuse  -0.001 -0.169, 0.167 2.84 2 
Note. CI = confidence interval 
* p < .05 
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Figure 1. PRISMA Flow Chart of Study Selection Strategy (Moher, Liberati, Tetzlaff, 
Altman & Group, 2009). 
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Figure 2. Scatterplot of Effect Sizes at Follow Up Points (in weeks).  
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Figure 3. Average effect sizes at follow up points (in weeks).  
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